Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma

被引：0
|
作者：
Xinglei Shen
Albert DeNittis
Maria Werner-Wasik
Rita Axelrod
Paul Gilman
Thomas Meyer
Joseph Treat
Walter J Curran
Mitchell Machtay
机构：
[1] Kimmel Cancer Center,Department of Radiation Oncology
[2] Jefferson Medical College of Thomas Jefferson University,Department of Radiation Oncology, Lankenau Hospital and Lankenau Institute for Medical Research
[3] Main Line Health System,Department of Medical Oncology, Kimmel Cancer Center
[4] Jefferson Medical College of Thomas Jefferson University,Department of Hematology/Oncology, Lankenau Hospital and Lankenau Institute for Medical Research
[5] Main Line Health System,Department of Radiation Oncology
[6] Eli Lilly,Department of Radiation Oncology
[7] Inc,undefined
[8] Emory University Hospital,undefined
[9] University Hospitals,undefined
来源：
Radiation Oncology | / 6卷
关键词：
Dose Level; Carboplatin; Esophagitis; Median Survival Time; Pemetrexed;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A dose escalation study of carboplatin plus vinorelbine for advanced non-small cell lung cancer
    Colleoni, M
    Nelli, I
    Gaion, F
    Pancheri, E
    Sgarbossa, G
    Manente, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1094 - 1094
  • [22] Feasibility of administration of dose-dense pemetrexed given every two weeks in patients with advanced non-small cell lung cancer
    Emmanouilides, Christos
    Serpanou, Anastasia
    Sapountzi, Evdoxia
    Mantziari, Polyxeni
    Philipou, Dimitrios
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S677 - S677
  • [23] Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy for Patients with Locally Advanced Non-small Cell Lung Cancer A Phase I Trial
    Heinzerling, John H.
    Choy, Hak
    Hughes, Randall S.
    Govindan, Ramaswamy
    Bradley, Jeffrey D.
    Schwartzberg, Lee S.
    Peng, Guangbin
    Treat, Joseph
    Tran, Taylor
    Obasaju, Coleman
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1391 - 1396
  • [24] Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Azuma, Koichi
    Zaizen, Yoshiaki
    Yamashita, Fumie
    Yoshida, Tsukasa
    Naito, Yoshiko
    Okayama, Yusuke
    Miyamoto, Maki
    Hoshino, Tomoaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 472 - 478
  • [25] Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer
    Schneider, Bryan J.
    Kalemkerian, Gregory P.
    Gadgeel, Shirish M.
    Valdivieso, Manuel
    Hackstock, Deborah M.
    Chen, Wei
    Heilbrun, Lance K.
    Ruckdeschel, John C.
    Wozniak, Antoinette J.
    CLINICAL LUNG CANCER, 2017, 18 (03) : 299 - 302
  • [26] Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer
    Scagliotti, GV
    Crinó, L
    Pozzi, E
    Corgna, E
    Selvaggi, G
    Novello, S
    Salsano, G
    Gentile, A
    Palladino, M
    Marracolo, F
    Tonato, M
    LUNG CANCER, 1999, 25 (01) : 39 - 46
  • [27] Concomitant pemetrexed/carboplatin chemotherapy and 3D conformal radiotherapy followed by pemetrexed/carboplatin consolidation chemotherapy for locally advanced non-small cell lung cancer: Preliminary results of a phase II study
    Ma, S.
    Xu, Y.
    Ji, Y.
    Sun, X.
    Cheng, J.
    Du, X.
    Zheng, Y.
    Qiu, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Paclitaxel and carboplatin: A phase I study in advanced non-small cell lung cancer
    Paccagnella, A
    Favaretto, A
    Oniga, F
    Ossana, L
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 76 - 79
  • [29] Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancer
    Takemoto, Shinnosuke
    Nakamura, Yoichi
    Fukuda, Minoru
    Senju, Hiroaki
    Gyotoku, Hiroshi
    Taniguchi, Hirokazu
    Shimada, Midori
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Hayashi, Nobuyuki
    Soda, Hiroshi
    Mukae, Hiroshi
    THORACIC CANCER, 2017, 8 (06) : 577 - 581
  • [30] Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study
    Giannakakis, T
    Ziras, N
    Kakolyris, S
    Mavroudis, D
    Androulakis, N
    Agelaki, S
    Parashos, M
    Sarra, E
    Dimou, T
    Hatzidaki, D
    Vlachonikolis, J
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (06) : 742 - 747
12345